| (+)-alpha-tocopherol | increases expression | ISO | RGD:2092 | 6480464 | alpha-Tocopherol results in increased expression of AKR1B1 mRNA | CTD | PMID:16908007 |
| 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of AKR1B1 mRNA | CTD | PMID:20566472 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of AKR1B1 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of AKR1B1 mRNA | CTD | PMID:19684285 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:736610 | 6480464 | Tetrachlorodibenzodioxin affects the expression of AKR1B3 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:2092 | 6480464 | Tetrachlorodibenzodioxin affects the expression of AKR1B1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of AKR1B1 mRNA | CTD | PMID:20106945 PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of AKR1B1 mRNA | CTD | PMID:19684285 |
| 2,3-dimethoxynaphthalene-1,4-dione | decreases expression | EXP | | 6480464 | 2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of AKR1B1 mRNA | CTD | PMID:17547211 |
| 2-acetamidofluorene | increases expression | ISO | RGD:736610 | 6480464 | 2-Acetylaminofluorene results in increased expression of AKR1B3 mRNA | CTD | PMID:17317680 |
| 2-heptenal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 2-heptenal | CTD | PMID:9890881 |
| 2-hexenal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 2-hexenal | CTD | PMID:21329684 PMID:9890881 |
| 2-hexenal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 2-hexenal | CTD | PMID:9890881 |
| 2-hexenal | affects reduction | EXP | | 6480464 | AKR1B1 protein affects the reduction of 2-hexenal | CTD | PMID:11306073 |
| 2-hexenal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 2-hexenal | CTD | PMID:9890881 PMID:21329684 |
| 2-hexenal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 2-hexenal metabolite | CTD | PMID:21329684 |
| 2-nonenal | affects reduction | EXP | | 6480464 | AKR1B1 protein affects the reduction of 2-nonenal | CTD | PMID:11306073 |
| 2-nonenal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 2-nonenal | CTD | PMID:9890881 |
| 2-octenal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 2-octenal | CTD | PMID:9890881 |
| 2-octenal | affects reduction | EXP | | 6480464 | AKR1B1 protein affects the reduction of 2-octenal | CTD | PMID:11306073 |
| 2-pentenal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 2-pentenal | CTD | PMID:9890881 |
| 2-pentenal | affects reduction | EXP | | 6480464 | AKR1B1 protein affects the reduction of 2-pentenal | CTD | PMID:11306073 |
| 3,4-dihydroxybenzoic acid | multiple interactions | ISO | RGD:736610 | 6480464 | protocatechuic acid inhibits the reaction [Galactose results in increased expression of AKR1B3 mRNA] | CTD | PMID:22687555 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:736610 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of AKR1B3 mRNA | CTD | PMID:18648102 |
| 4-hydroxynon-2-enal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 4-hydroxy-2-nonenal | CTD | PMID:9890881 more ... |
| 4-hydroxynon-2-enal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 4-hydroxy-2-nonenal | CTD | PMID:10510318 more ... |
| 4-hydroxynon-2-enal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 4-hydroxy-2-nonenal | CTD | PMID:21329684 more ... |
| 4-hydroxynon-2-enal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 4-hydroxy-2-nonenal | CTD | PMID:10510318 more ... |
| 4-hydroxynon-2-enal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 4-hydroxy-2-nonenal metabolite | CTD | PMID:21329684 |
| 4-hydroxynon-2-enal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 4-hydroxy-2-nonenal | CTD | PMID:9890881 PMID:10510318 |
| 4-hydroxynon-2-enal | affects reduction | EXP | | 6480464 | AKR1B1 protein affects the reduction of 4-hydroxy-2-nonenal | CTD | PMID:11306073 |
| 4-hydroxynon-2-enal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 4-hydroxy-2-nonenal | CTD | PMID:21329684 more ... |
| 4-nitrobenzaldehyde | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 4-nitrobenzaldehyde | CTD | PMID:10510318 |
| 9,10-phenanthroquinone | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of 9,10-phenanthrenequinone | CTD | PMID:10510318 |
| 9,10-phenanthroquinone | multiple interactions | EXP | | 6480464 | AKR1B1 protein results in increased reduction of and affects the activity of 9,10-phenanthrenequinone | CTD | PMID:21910479 |
| acrolein | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of Acrolein | CTD | PMID:9890881 more ... |
| acrolein | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of Acrolein | CTD | PMID:9890881 more ... |
| acrolein | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of Acrolein | CTD | PMID:21329684 more ... |
| acrolein | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of Acrolein | CTD | PMID:21329684 more ... |
| acrolein | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of Acrolein metabolite | CTD | PMID:21329684 |
| acrolein | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of Acrolein | CTD | PMID:10510318 more ... |
| acrolein | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of Acrolein | CTD | PMID:10510318 PMID:9890881 |
| acrolein | affects reduction | EXP | | 6480464 | AKR1B1 protein affects the reduction of Acrolein | CTD | PMID:11306073 |
| aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of AKR1B1 protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of AKR1B1 mRNA | CTD | PMID:22100608 |
| all-trans-dehydroretinal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of dehydroretinal | CTD | PMID:19014918 |
| all-trans-retinal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of Retinaldehyde | CTD | PMID:19014918 |
| all-trans-retinol | decreases response to substance | EXP | | 6480464 | AKR1B1 protein results in decreased susceptibility to Vitamin A; more ... | CTD | PMID:19014918 |
| alpha-hexylcinnamaldehyde | increases expression | EXP | | 6480464 | hexyl cinnamic aldehyde results in increased expression of AKR1B1 mRNA | CTD | PMID:20566472 |
| ammonium chloride | affects expression | ISO | RGD:2092 | 6480464 | Ammonium Chloride affects the expression of AKR1B1 mRNA | CTD | PMID:16483693 |
| antimony(0) | decreases expression | EXP | | 6480464 | Antimony results in decreased expression of AKR1B1 mRNA | CTD | PMID:17547211 |
| Bandrowski's base | increases expression | EXP | | 6480464 | Bandrowski's base results in increased expression of AKR1B1 mRNA | CTD | PMID:20566472 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of AKR1B1 mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | increases expression | ISO | RGD:2092 | 6480464 | Benzo(a)pyrene results in increased expression of AKR1B1 protein | CTD | PMID:16456883 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:2092 | 6480464 | Benzo(a)pyrene promotes the reaction [sodium arsenite results in increased expression of AKR1B1 protein]; more ... | CTD | PMID:16456883 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:2092 | 6480464 | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of AKR1B1 mRNA | CTD | PMID:18711122 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of AKR1B1 mRNA; more ... | CTD | PMID:17690111 |
| benzo[a]pyrene | increases expression | ISO | RGD:736610 | 6480464 | Benzo(a)pyrene results in increased expression of AKR1B3 mRNA | CTD | PMID:20127859 PMID:22228805 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of AKR1B1 mRNA | CTD | PMID:20106945 PMID:22316170 |
| benzo[a]pyrene | increases expression | ISO | RGD:736610 | 6480464 | Benzo(a)pyrene results in increased expression of AKR1B3 mRNA | CTD | PMID:20127859 |
| benzo[b]fluoranthene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of AKR1B1 mRNA | CTD | PMID:17690111 |
| benzoic acid | increases expression | EXP | | 6480464 | Benzoic Acid results in increased expression of AKR1B1 mRNA | CTD | PMID:20566472 |
| benzyl alcohol | increases oxidation | EXP | | 6480464 | AKR1B1 protein results in increased oxidation of Benzyl Alcohol | CTD | PMID:17194029 |
| butanal | affects reduction | EXP | | 6480464 | AKR1B1 protein affects the reduction of butyraldehyde | CTD | PMID:11306073 |
| butanal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of butyraldehyde | CTD | PMID:9890881 |
| cadmium atom | decreases expression | EXP | | 6480464 | Cadmium results in decreased expression of AKR1B1 mRNA | CTD | PMID:17547211 |
| cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of AKR1B1 mRNA | CTD | PMID:17547211 |
| candesartan | decreases expression | ISO | RGD:2092 | 6480464 | candesartan results in decreased expression of AKR1B1 mRNA | CTD | PMID:14871019 |
| capecitabine | decreases response to substance | EXP | | 6480464 | AKR1B1 protein results in decreased susceptibility to capecitabine | CTD | PMID:16734730 |
| carboplatin | increases expression | ISO | RGD:2092 | 6480464 | Carboplatin results in increased expression of AKR1B1 mRNA | CTD | PMID:18172885 |
| carmustine | affects response to substance | EXP | | 6480464 | AKR1B1 mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 |
| cefaloridine | increases expression | ISO | RGD:2092 | 6480464 | Cephaloridine results in increased expression of AKR1B1 mRNA | CTD | PMID:18172885 |
| choline | multiple interactions | ISO | RGD:736610 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of AKR1B3 mRNA | CTD | PMID:20938992 |
| chromium atom | decreases expression | EXP | | 6480464 | Chromium results in decreased expression of AKR1B1 mRNA | CTD | PMID:17547211 |
| cinnamyl alcohol | increases expression | EXP | | 6480464 | cinnamyl alcohol results in increased expression of AKR1B1 mRNA | CTD | PMID:20566472 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of AKR1B1 protein | CTD | PMID:16803524 |
| cisplatin | increases phosphorylation | ISO | RGD:736610 | 6480464 | Cisplatin results in increased phosphorylation of AKR1B3 protein | CTD | PMID:22006019 |
| cisplatin | increases expression | ISO | RGD:2092 | 6480464 | Cisplatin results in increased expression of AKR1B1 mRNA | CTD | PMID:18172885 |
| copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of AKR1B1 mRNA | CTD | PMID:20971185 |
| copper atom | decreases expression | ISO | RGD:2092 | 6480464 | Copper deficiency results in decreased expression of AKR1B1 protein | CTD | PMID:18993053 |
| copper atom | increases expression | ISO | RGD:2092 | 6480464 | Copper results in increased expression of AKR1B1 mRNA | CTD | PMID:22465980 |
| copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of AKR1B1 mRNA | CTD | PMID:20971185 |
| copper(0) | decreases expression | ISO | RGD:2092 | 6480464 | Copper deficiency results in decreased expression of AKR1B1 protein | CTD | PMID:18993053 |
| copper(0) | increases expression | ISO | RGD:2092 | 6480464 | Copper results in increased expression of AKR1B1 mRNA | CTD | PMID:22465980 |
| curcumin | increases expression | ISO | RGD:736610 | 6480464 | Curcumin results in increased expression of AKR1B1 mRNA | CTD | PMID:18200517 |
| curcumin | increases expression | ISO | RGD:2092 | 6480464 | Curcumin results in increased expression of AKR1B1 mRNA | CTD | PMID:18588981 more ... |
| curcumin | increases expression | ISO | RGD:2092 | 6480464 | Curcumin results in increased expression of AKR1B1 protein | CTD | PMID:17640564 PMID:18588981 |
| curcumin | multiple interactions | ISO | RGD:2092 | 6480464 | NFE2L2 protein promotes the reaction [Curcumin results in increased expression of AKR1B1 mRNA] | CTD | PMID:17640564 PMID:18588981 |
| curcumin | increases expression | ISO | RGD:2092 | 6480464 | Curcumin results in increased expression of AKR1B1 mRNA | CTD | PMID:18299980 more ... |
| curcumin | increases expression | ISO | RGD:2092 | 6480464 | Curcumin results in increased expression of AKR1B1 mRNA | CTD | PMID:17640564 more ... |
| curcumin | multiple interactions | ISO | RGD:2092 | 6480464 | NFE2L2 protein promotes the reaction [Curcumin results in increased expression of AKR1B1 mRNA] | CTD | PMID:18588981 PMID:17640564 |
| curcumin | increases expression | ISO | RGD:2092 | 6480464 | Curcumin results in increased expression of AKR1B1 mRNA | CTD | PMID:18299980 more ... |
| curcumin | increases expression | ISO | RGD:2092 | 6480464 | Curcumin results in increased expression of AKR1B1 protein | CTD | PMID:18588981 PMID:17640564 |
| curcumin | increases activity | ISO | RGD:2092 | 6480464 | Curcumin results in increased activity of AKR1B1 protein | CTD | PMID:17640564 |
| curcumin | multiple interactions | ISO | RGD:2092 | 6480464 | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Curcumin results in increased expression of AKR1B1 protein]; more ... | CTD | PMID:18588981 |
| curcumin | multiple interactions | ISO | RGD:2092 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Curcumin results in increased expression of AKR1B1 mRNA]; more ... | CTD | PMID:17640564 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of AKR1B1 mRNA | CTD | PMID:20106945 |
| D-glucose | increases expression | ISO | RGD:736610 | 6480464 | Glucose results in increased expression of AKR1B3 mRNA; more ... | CTD | PMID:16805838 |
| D-glyceraldehyde | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of Glyceraldehyde | CTD | PMID:19014918 |
| daunorubicin | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of Daunorubicin | CTD | PMID:10510318 |
| decanal | affects reduction | EXP | | 6480464 | AKR1B1 protein affects the reduction of decanaldehyde | CTD | PMID:11306073 |
| decanal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of decanaldehyde | CTD | PMID:9890881 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of AKR1B1 mRNA | CTD | PMID:17547211 |
| dibenz[a,h]anthracene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of AKR1B1 mRNA | CTD | PMID:17690111 |
| dibenz[a,h]anthracene | multiple interactions | ISO | RGD:2092 | 6480464 | [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of AKR1B1 mRNA; more ... | CTD | PMID:18711122 |
| dibenzo[a,l]pyrene | multiple interactions | ISO | RGD:2092 | 6480464 | [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of AKR1B1 mRNA | CTD | PMID:18711122 |
| dibutyl phthalate | decreases expression | ISO | RGD:2092 | 6480464 | Dibutyl Phthalate results in decreased expression of AKR1B1 mRNA | CTD | PMID:21266533 |
| dioxygen | multiple interactions | ISO | RGD:2092 | 6480464 | AKR1B1 protein inhibits the reaction [Oxygen deficiency results in increased phosphorylation of EIF2A protein]; more ... | CTD | PMID:19041636 |
| dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | decreases expression | EXP | | 6480464 | Antimony Potassium Tartrate results in decreased expression of AKR1B1 mRNA | CTD | PMID:17547211 |
| disulfiram | increases expression | EXP | | 6480464 | Disulfiram results in increased expression of AKR1B1 mRNA | CTD | PMID:20566472 |
| diuron | increases expression | ISO | RGD:2092 | 6480464 | Diuron results in increased expression of AKR1B1 mRNA | CTD | PMID:21551480 |
| ethanol | decreases expression | ISO | RGD:2092 | 6480464 | Ethanol results in decreased expression of AKR1B1 mRNA | CTD | PMID:15353170 |
| eugenol | increases expression | EXP | | 6480464 | Eugenol results in increased expression of AKR1B1 mRNA | CTD | PMID:20566472 |
| fluoranthene | multiple interactions | ISO | RGD:2092 | 6480464 | [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of AKR1B1 mRNA | CTD | PMID:18711122 |
| fluoranthene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of AKR1B1 mRNA | CTD | PMID:17690111 |
| flutamide | increases expression | ISO | RGD:2092 | 6480464 | Flutamide results in increased expression of AKR1B1 protein | CTD | PMID:17311803 |
| folic acid | multiple interactions | ISO | RGD:736610 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of AKR1B3 mRNA | CTD | PMID:20938992 |
| fonofos | increases methylation | EXP | | 6480464 | Fonofos results in increased methylation of AKR1B1 promoter | CTD | PMID:22847954 |
| galactose | multiple interactions | ISO | RGD:736610 | 6480464 | protocatechuic acid inhibits the reaction [Galactose results in increased expression of AKR1B3 mRNA] | CTD | PMID:22687555 |
| galactose | increases expression | ISO | RGD:736610 | 6480464 | Galactose results in increased expression of AKR1B3 mRNA | CTD | PMID:22687555 |
| glucose | increases expression | ISO | RGD:736610 | 6480464 | Glucose results in increased expression of AKR1B3 mRNA; more ... | CTD | PMID:16805838 |
| glutathione | increases glutathionylation | EXP | | 6480464 | Glutathione results in increased glutathionylation of AKR1B1 protein modified form | CTD | PMID:19061876 |
| glutathione | increases reduction | EXP | | 6480464 | Glutathione results in increased reduction of AKR1B1 protein modified form | CTD | PMID:19061876 |
| glutathione | affects binding | EXP | | 6480464 | AKR1B1 protein binds to Glutathione | CTD | PMID:11306073 |
| glyceraldehyde | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of Glyceraldehyde | CTD | PMID:19014918 |
| glyoxal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of Glyoxal | CTD | PMID:10510318 |
| hexane | increases expression | EXP | | 6480464 | n-hexane results in increased expression of AKR1B1 mRNA | CTD | PMID:20566472 |
| hypochlorous acid | increases expression | ISO | RGD:736610 | 6480464 | Hypochlorous Acid results in increased expression of AKR1B3 mRNA | CTD | PMID:19376150 |
| isatin | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of Isatin | CTD | PMID:10510318 |
| isoeugenol | increases expression | EXP | | 6480464 | isoeugenol results in increased expression of AKR1B1 mRNA | CTD | PMID:20566472 |
| L-ascorbic acid | increases reduction | EXP | | 6480464 | Ascorbic Acid results in increased reduction of AKR1B1 protein modified form | CTD | PMID:19061876 |
| L-methionine | multiple interactions | ISO | RGD:736610 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of AKR1B3 mRNA | CTD | PMID:20938992 |
| lactic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of AKR1B1 mRNA | CTD | PMID:20566472 |
| LY294002 | multiple interactions | ISO | RGD:2092 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Curcumin results in increased expression of AKR1B1 mRNA] | CTD | PMID:17640564 |
| maneb | multiple interactions | ISO | RGD:736610 | 6480464 | [Paraquat co-treated with Maneb] results in decreased expression of AKR1B3 mRNA | CTD | PMID:18386188 |
| manganese(II) chloride | increases expression | ISO | RGD:2092 | 6480464 | manganese chloride results in increased expression of AKR1B1 mRNA | CTD | PMID:22281203 |
| mercury atom | decreases expression | EXP | | 6480464 | Mercury results in decreased expression of AKR1B1 mRNA | CTD | PMID:17547211 |
| mercury(0) | decreases expression | EXP | | 6480464 | Mercury results in decreased expression of AKR1B1 mRNA | CTD | PMID:17547211 |
| methyl salicylate | increases expression | EXP | | 6480464 | methyl salicylate results in increased expression of AKR1B1 mRNA | CTD | PMID:20566472 |
| methylglyoxal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of Pyruvaldehyde | CTD | PMID:10510318 |
| methylphenidate | decreases expression | ISO | RGD:736610 | 6480464 | Methylphenidate results in decreased expression of AKR1B3 mRNA | CTD | PMID:22470460 |
| microcystin-LR | increases expression | ISO | RGD:736610 | 6480464 | cyanoginosin LR results in increased expression of AKR1B3 mRNA | CTD | PMID:17654400 |
| morphine | decreases expression | ISO | RGD:2092 | 6480464 | Morphine results in decreased expression of AKR1B1 protein | CTD | PMID:23056601 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:2092 | 6480464 | Diethylnitrosamine results in increased expression of AKR1B1 mRNA | CTD | PMID:19638242 |
| N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of AKR1B1 mRNA | CTD | PMID:17547211 |
| NADP zwitterion | multiple interactions | EXP | | 6480464 | [AKR1B1 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7,8-dihydrodiol; more ... | CTD | PMID:21910479 |
| NADP(+) | multiple interactions | EXP | | 6480464 | [AKR1B1 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7,8-dihydrodiol; more ... | CTD | PMID:21910479 |
| nickel dichloride | decreases expression | EXP | | 6480464 | nickel chloride results in decreased expression of AKR1B1 mRNA | CTD | PMID:17547211 |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of AKR1B1 mRNA | CTD | PMID:20566472 |
| octanal | affects reduction | EXP | | 6480464 | AKR1B1 protein affects the reduction of caprylic aldehyde | CTD | PMID:11306073 |
| paclitaxel | increases response to substance | EXP | | 6480464 | AKR1B1 protein results in increased susceptibility to Paclitaxel | CTD | PMID:16734730 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of AKR1B1 mRNA | CTD | PMID:22230336 |
| paraquat | multiple interactions | ISO | RGD:736610 | 6480464 | [Paraquat co-treated with Maneb] results in decreased expression of AKR1B3 mRNA | CTD | PMID:18386188 |
| parathion | increases methylation | EXP | | 6480464 | Parathion results in increased methylation of AKR1B1 promoter | CTD | PMID:22847954 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of AKR1B1 mRNA | CTD | PMID:19084549 |
| phenobarbital | affects expression | ISO | RGD:736610 | 6480464 | Phenobarbital affects the expression of AKR1B3 mRNA | CTD | PMID:23091169 |
| pirinixic acid | decreases activity | EXP | | 6480464 | pirinixic acid results in decreased activity of AKR1B1 protein | CTD | PMID:17194029 |
| potassium dichromate | decreases expression | EXP | | 6480464 | Potassium Dichromate results in decreased expression of AKR1B1 mRNA | CTD | PMID:17547211 |
| propan-2-ol | increases expression | EXP | | 6480464 | 2-Propanol results in increased expression of AKR1B1 mRNA | CTD | PMID:20566472 |
| propanal | affects reduction | EXP | | 6480464 | AKR1B1 protein affects the reduction of propionaldehyde analog | CTD | PMID:11306073 |
| propanal | increases reduction | EXP | | 6480464 | AKR1B1 protein results in increased reduction of propionaldehyde | CTD | PMID:9890881 |
| prostaglandin E2 | multiple interactions | EXP | | 6480464 | [sorbinil results in decreased activity of AKR1B1 protein] inhibits the reaction [Lipopolysaccharides results in increased secretion of Dinoprostone]; more ... | CTD | PMID:21334316 |
| pterostilbene | multiple interactions | ISO | RGD:736610 | 6480464 | pterostilbene inhibits the reaction [Azoxymethane results in increased expression of AKR1B3 protein]; more ... | CTD | PMID:21355597 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of AKR1B1 mRNA | CTD | PMID:21632981 |
| resveratrol | multiple interactions | ISO | RGD:736610 | 6480464 | resveratrol inhibits the reaction [Azoxymethane results in increased expression of AKR1B3 mRNA]; more ... | CTD | PMID:21355597 |
| sodium dodecyl sulfate | increases expression | EXP | | 6480464 | Sodium Dodecyl Sulfate results in increased expression of AKR1B1 mRNA | CTD | PMID:20566472 |
| sorbinil | decreases activity | EXP | | 6480464 | sorbinil results in decreased activity of AKR1B1 protein | CTD | PMID:21334316 |
| sorbinil | multiple interactions | EXP | | 6480464 | [sorbinil results in decreased activity of AKR1B1 protein] which results in decreased susceptibility to TNF protein; more ... | CTD | PMID:21334316 |
| streptozocin | multiple interactions | ISO | RGD:736610 | 6480464 | AKR1B3 inhibits the reaction [Streptozocin results in increased abundance of Glycosylation End Products, Advanced]; more ... | CTD | PMID:21276777 |
| temozolomide | affects response to substance | EXP | | 6480464 | AKR1B1 mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 |
| terbufos | increases methylation | EXP | | 6480464 | terbufos results in increased methylation of AKR1B1 promoter | CTD | PMID:22847954 |
| titanium dioxide | decreases phosphorylation | EXP | | 6480464 | titanium dioxide results in decreased phosphorylation of AKR1B1 protein | CTD | PMID:21439344 |
| trans-resveratrol | multiple interactions | ISO | RGD:736610 | 6480464 | resveratrol inhibits the reaction [Azoxymethane results in increased expression of AKR1B3 mRNA]; more ... | CTD | PMID:21355597 |
| valproic acid | affects expression | ISO | RGD:736610 | 6480464 | Valproic Acid affects the expression of AKR1B3 mRNA | CTD | PMID:17963808 |